PARP1 and acute myeloid leukemia: Commonly used AML cell lines were evaluated for two characteristic parthanatos features: the formation of chromatin ring structures (Figures 3A–3D) and the impact of PARP inhibition by olaparib on cell viability (Figures 3E–3H) upon treatment with ara-C and idarubicin.